$HNGE

Jim Cramer Says Hinge Health “Delivered a True Blowout Set of Numbers”

On Jim Cramer’s “Mad Money,” he discussed Hinge Health (NYSE:HNGE) after the company reported strong results. Cramer said revenue rose 47% year over year, margins beat expectations, and earnings topped estimates. He noted management raised current-quarter guidance and substantially lifted the full-year forecast, and the stock jumped about 10% in one session, then traded sideways.

Original reporting
Published Jun 3, 2026, 5:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 3, 2026, 5:44 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Jim Cramer Says Hinge Health “Delivered a True Blowout Set of Numbers” — source image
Decision brief

The 30-second read

$HNGEBullishLow
01

Why it matters

The key tradable takeaway is the combination of a strong earnings beat (revenue +47% YoY, margin strength, healthy earnings) and raised guidance, which drove an initial ~10% jump; the article then notes the stock has since moved into a sideways consolidation.

02

Market read

HNGE is highlighted as a recent earnings winner with raised forecasts, but the lack of new information suggests limited incremental trading edge today.

03

What to watch

No details on valuation, competitive dynamics, or whether guidance was driven by one-time factors; sideways trading suggests limited incremental demand after the initial reaction.

Relevance 8/10Novelty 2/10Timing: after-hours/next-session context following the prior earnings reaction (stock jumped ~10% single session; now trading sideways)

Background

Hinge Health is a digital AI-powered physical therapy platform that went public about a year ago; it had earlier strength, then lagged, before the recent earnings catalyst.

Company-level read

Ticker impact

$HNGEBullishMedium confidence
Context

Cramer cites Hinge Health’s earnings as a “blowout,” with revenue +47% YoY, margin strength, and raised guidance after the stock jumped ~10%.

Expected impact

Near-term: range-bound unless follow-through appears; medium-term: bias to upside if raised guidance sustains.

Evidence & confidence

The piece highlights specific earnings/guidance datapoints and the immediate single-session reaction, but provides no new incremental datapoints beyond that recap/opinion.

Market effects

Supports investor appetite for AI-enabled digital health/virtual care platforms via a demonstrated earnings/guidance beat.

None stated.

None stated.

Counterpoint

The article may overemphasize the earnings beat; with the stock already up and “trading sideways,” the market may be waiting for the next proof point.

Key entities

  • Hinge Health, Inc.

    Digital AI-powered physical therapy platform; cited for a blowout earnings quarter and raised guidance.

Related articles

$HNGEHighAI 9/10

Why is Hinge Health stock surging today?

Hinge Health (HNGE) shares rose 11.6% after the company reported Q2 2026 revenue of $212.8M (+53% YoY) and non-GAAP diluted EPS of $0.59 vs $0.13 consensus. Free cash flow exceeded $100M. Hinge raised FY2026 revenue guidance to $818M-$824M and Q3 guidance to $223M-$225M, and agreed to buy Cylinder Health for $105M cash. Analysts lifted price targets.

$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.

$HBBMed

Hamilton Beach Brands Q2 Earnings Call Highlights

Hamilton Beach Brands (HBB) reported Q2 gross margin of 26.1% excluding tariff-related benefits, and said it expects 2026 revenue growth in the mid-single-digit range. Management forecast full-year gross margin to improve modestly and operating profit to decline by a high-single-digit percentage. Operating cash flow is expected at $35M to $45M. HBB ended with net cash of $51.5M.